February 03, 2023
Bulletin interne de l'Institut Pasteur
This one-day symposium, co-organized by the Société de Chimie Thérapeutique (SCT), Evotec and the Institut Pasteur, will cover outstanding innovation and applied state-of-the-art molecular design contributing to an advance to drug discovery boundaries. Selected themes of the symposium will be dedicated to "breakthrough" discoveries or innovative technologies/methods and may include the application of machine learning (ML) and artificial intelligence (AI).
This event, part of the Drug Discovery & Screening (ATC-DDS) in the Strategic Plan, will be held on March 14 in the Emile Duclaux lecture hall.
The following speakers have already confirmed their presence:
Dr Christoph Grebner (Sanofi, Frankfurt, Germany)
Dr Raquel Rodriguez Perez (Novartis, Bale, Switzerland)
Dr Fredrick Zetterberg (Galecto Biotech, Copenhagen, Denmark)
Andreas Luttens (University of Uppsala, Uppsala, Sweden), winner of the 2022 Evotec prize for Excellence in Molecular Design.
Dr Stefania Monteleone (Evotec, Abingdon, United Kingdom)
Dr Merveille Eguida (University of Strasbourg, France)
Dr Gilles Labesse (CBS, Montpellier, France)
Drs Christophe Zimmer and Bogdan Ciambur (Institut Pasteur, Paris, France)
Registration is now open (and will be open until March 7 2023).
A precise agenda with titles and abstracts will be available soon.
If you have any questions or require further information, please contact Emilie Boutet: emilie.boutet@pasteur.fr